On the Cusp of Completely Implantable Cochlear Implants
With several completely implantable CIs in development, a new device choice for patients with severe-to-profound hearing loss is on the horizon.
With several completely implantable CIs in development, a new device choice for patients with severe-to-profound hearing loss is on the horizon.
Cochlear Limited (ASX: COH) announced the promotion of Lisa Aubert, currently the Vice President of Sales for Cochlear Americas, to the role of President for Cochlear Americas on April 1, 2022. The role is responsible for the development and execution of the strategic direction for the United States and Canadian operations.Â
Neuromod announces the appointment of Deborah Arthur as Head of Quality and Regulatory Affairs, Suzanne O’Rourke as Director of Quality and Regulatory Affairs, and Cathal Mc Fadden as Director of Operations.
Leveraging telehealth within the cochlear implant industry provides clinics with more options to care for their patients no matter where their office is located, and it allows Nucleus Cochlear Implant recipients to receive care from the comfort of their own home.
Read MoreThe remote programming feature is indicated for patients who have had six months of experience with their cochlear implant sound processor and are comfortable with the programming process.
Read MoreEarlens Corporation, Inc., Menlo Park, Calif—a privately held medical technology company that created and commercialized a revolutionary hearing aid—announced the final close of its $73 million Series C preferred stock financing, and establishment of a structured debt facility with CRG LP for up to $45 million.
Read MoreConsumers are invited to HLAA2017, a communication-accessible educational program and trade show for people with hearing loss, hosted by the Hearing Loss Association of America (HLAA), the organization announced.
Read MoreThe Hearing Loss Association of America (HLAA)—an organization dedicated to educating, advocating, and supporting individuals with hearing loss—is thrilled to announce its 20 Walk4Hearing events across the nation this year, including two new locations in Buffalo, NY and Louisville, KY.
Read MoreHear the Music Project, a hearing health mobile clinic designed by nonprofit Songs for Sound, will visit nine locations in Colorado in late April and May.
Read MoreIn recognition of May’s Better Hearing & Speech Month, the Good Vibrations Music & Arts Festival (GVMAF) will host the first fully-encompassing deaf and hard-of-hearing accessible concert on May 20, 2017 at the 1850 Settlement in San Antonio, Texas. Ticket sales and festival commissions will benefit Texas-based nonprofit, Aid the Silent.
Read MoreProf Dorothea Kolossa and Mahdie Karbasi from the research group Cognitive Signal Processing at Ruhr-Universität Bochum (RUB) have developed a method for predicting speech intelligibility in noisy surroundings.
Read MoreCochlear is donating funding to support and promote CELEBRATE SOUND Don’t Walk in Silence events.
Read MoreCochlear Limited announces the launch of the Cochlear Nucleus Profile Implant with Slim Modiolar Electrode (CI532), designed to preserve hearing structures, boost hearing performance, and be easier for surgeons to use.
Read MoreCochlear Limited reports FDA approval of Nucleus implants for MRI up to 3.0T with magnet removal, and with use of an implant Bandage and Splint Kit, the implants are approved for 1.5T MRI with magnet in place.
Read MoreOne to six in 1,000 children in the US are born with severe to profound hearing loss. Parents of these children need information and support, which Cochlear helps provide via IWantYoutoHear.com.
Read MoreCochlear Limited received FDA clearance of the Cochlear Baha 5 SuperPower Sound Processor for use in the US. The “Smart” bone conduction processor has direct-to-device wireless technology for patients with significant hearing loss. US availability is anticipated for summer 2016.
Read MoreAccording to early findings from a multi-center study led by specialists at NYU Langone Medical Center, people with a common form of hearing loss not helped by hearing aids achieved significant improvements in their hearing and understanding of speech with hybrid cochlear implants.
Read MoreThe FDA has approved the Nucleus 6 Sound Processor, which is a technology upgrade with many advanced features for the Nucleus 22 cochlear implant from Cochlear Limited.
Read More